Although a trend toward reduction was observed for cardiovascular death (pooled HR 0.90, 95% CI 0.78–1.04), it did not reach statistical significance.
← all excerpts
Uniform efficacy of SGLT2 inhibitors across the ejection fraction spectrum and in high-risk patients with HFpEF: a prespecified pooled analysis.
1
—
—